Firouz Asgarzadeh
Articles
Regulatory Considerations for Alcohol-Induced Dose Dumping of Oral Modified-Release Formulations
Kevin Hughes;Ann Gray;Firouz Asgarzadeh;Yvonne Rosiaux;Johann-Philipp Hebestreit;Thomas P. Friebe;Amina Faham;Mahmud Yunis
October 2nd 2015This article looks at the current status of alcohol-induced dose dumping of modified-release formulations and the need for regulatory harmonization in handling this challenge.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: November 25th 2024 | Updated: December 24th 2024
Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics
Published: December 20th 2024 | Updated: December 24th 2024
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Published: February 23rd 2024 | Updated: December 24th 2024
Europa Perspectives: Helping to Navigate the Regulatory System
Published: December 13th 2024 | Updated: December 24th 2024
FDA Creates CDER Center for Real-World Evidence Innovation
